Dark Forest Capital Management’s Emergent Biosolutions EBS Stock Holding History

Dark Forest Capital Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-17,491	Closed	-$112K	–	1239
2025 Q2	$112K	Buy	17,491 +3,925	+29%	+$22.5K	﹤0.01%	1119
2025 Q1	$65.9K	Buy	+13,566	New	+$112K	﹤0.01%	1182
2023 Q3	–	Sell	-71,553	Closed	-$526K	–	1137
2023 Q2	$526K	Buy	+71,553	New	+$664K	0.05%	608
2022 Q4	–	Sell	-315	Closed	-$7K	–	1237
2022 Q3	$7K	Buy	+315	New	+$8.77K	﹤0.01%	813
2022 Q1	–	Sell	-100	Closed	-$4K	–	1400
2021 Q4	$4K	Buy	+100	New	+$4.52K	﹤0.01%	1220
2021 Q3	–	Sell	-6	Closed	–	–	1331
2021 Q2	$0	Buy	+6	New	+$385	﹤0.01%	814

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OHA

Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dark Forest Capital Management's EBS Position: Q3 2025 in Review

Dark Forest Capital Management sold out of Emergent Biosolutions (EBS) in Q3 2025, closing a stake of 17,491 shares — an estimated $112K sold.

Dark Forest Capital Management first reported a position in EBS in Q2 2021 and held it in 6 quarters. The position peaked at $526K in Q2 2023. 169 funds tracked by Wall St. Rank hold EBS as of Q3 2025.

Dark Forest Capital Management reported no remaining Emergent Biosolutions position as of Q3 2025 after selling out during the quarter.
Dark Forest Capital Management sold 17,491 Emergent Biosolutions shares in Q3 2025, an estimated $112K.
Dark Forest Capital Management first reported a position in Emergent Biosolutions in Q2 2021 and held it in 6 quarters.
Dark Forest Capital Management's Emergent Biosolutions position peaked at $526K in Q2 2023.
169 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2025.

Based on Dark Forest Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.